Novo outlines new late-stage study of obesity drug CagriSema US$ 21.30 Min. order: 1 piece ★★★★★ 4.7 (108 reviews) Sold : Login>>
CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 20.32 Min. order: 1 piece ★★★★★ 4.3 (82 reviews) Sold : Login>>
Structural Biophysics-Guided Computational Design of Semaglutide Analogues to Enhance GLP-1R Activation - Article (Preprint v1) by Wei Li US$ 22.81 Min. order: 1 piece ★★★★★ 4.7 (75 reviews) Sold : Login>>
Dual Therapy CagriSema Promising for Weight and Glycaemic Control US$ 28.54 Min. order: 1 piece ★★★★★ 4.2 (288 reviews) Sold : Login>>